Leukemia Relapse Clinical Trials in Berlin
2 recruitingBerlin, Germany
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies
Leukemia RelapseLymphoma Diffuse Large B-cellLeukemia and Lymphoma+1 more
AvenCell Therapeutics, Inc.178 enrolled13 locationsNCT07284433
Recruiting
Phase 1Phase 2
Tafasitamab (MOR00208) in Pediatric Patients With Relapsed or Refractory Acute B Lineage Leukemia
ALL, Childhood B-CellAcute Lymphoid Leukemia RelapseAcute Lymphocytic Leukemia Refractory
University Hospital Tuebingen20 enrolled11 locationsNCT05366218